Report : Bovine Pericardial Valve Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Valve Type (Aortic, Mitral, Others); Alloy (Cobalt-chrome, Titanium, Nickel Molybdenum, Others); End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers) and Geography
Bovine Pericardial Valve Market for Aortic Valves to Grow at Highest CAGR during 2020-2027
According to our new marketresearch study on "Bovine Pericardial Valve Marketto 2027 - Global Analysis and Forecast by Valve Type Alloy, and End User, the market is expected to reach US$ 4,134.4 millionby 2027 from US$ 1,959.7millionin 2019; it is estimated to grow at a CAGR of 9.9% from 2020 to 2027. Thereport highlights trends prevailing in the market, and the drivers andrestraints pertaining to the market growth.
Based on the valvetype, theglobal bovine pericardial valve market is segmented into aortic, mitral, andothers. The aortic segment estimated to register the highest CAGR in the marketduring the forecast period. The projected growth of the aortic valves market isattributed tothe increasing preference for minimally invasive surgeries, andrising prevalence of cardiovascular diseases (CVDs).
The growth of the global bovinepericardial valvemarket isascribed to the factors such asincreasing incidenceof cardiovascular diseases and congenital heart diseases (CHDs), and advantagesof tissue valves over mechanical valves. However, the limitations associatedwith tissue-based valves restrain the market growth.
Medtronic, EdwardsLifesciences Corporation, Boston Scientific Corporation, Abbott, LivaNova PLC,BraileBiomedica, Meril Life Sciences Pvt. Ltd., Valcare Medical, Labcor, andAFFLUENT MEDICAL SA.,are among the leading companies operating in the bovinepericardial valve market.
The report segments global bovine pericardial valve market asfollows:
By End User